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CHAPTER I 
INTRODUCTION 
Recent advances in the study of food chemistry have revealed a 
large variety of compounds to be responsible for both flavor and/or 
aroma. In roasted foods nitrogenous heterocycles, pyrazines, have been 
implicated to be of particular organoleptic significance. Staudinger 
and Reichstein (1), were the first to report pyrazines in foods. A 
recent review by Maga and Sizer (2), lists seventy different pyrazines 
which have been identified in a variety of foods. 
It has been proposed by several investigators, Dawes and Edwards 
(3), Rizzi (4), Mason et al. (5), and Wang et al. (6), that pyrazines 
are formed via a thermal cleavage of sugars into dicarbonyl fragments 
which undergo further reactions with a-amino acids, equation 1. 
R' NYC02H R~ ,...NH2 :x ""' . c -""""'4·~~ · . ~ R L;HQ +C02 + 11 ~ R'' ~C R 0 · . R"'" 'OH 
(1) 
~!though this mechanism involves the formation of dihydropyrazines as 
intermediates, their presence in foods has never been experimentally 
established. The difficulty of detecting dihydropyrazines has been 
1 
attributed by Bondarovich et al. (7) and by Juneja and Odell (8) to the 
--
relative instability of these compounds and the harsh treatments used 
to isolate basic compounds from foods. These methods, as reviewed by 
Maga and Sizer (2), . generally involve steam distillation followed by 
concentration of the condensate, and fractionation using acidic and 
basic reagents. The basic fraction is then extracted with solvents 
prior to gas-liquid chromatographic analysis. In addition, Bondarovich 
et al. (7) have reported that some dihydropyrazines are unstable under 
--
certain gas-liquid chromatographic conditions. Thus, even though the 
reaction mechanism dictates the intermediate formation of dihydropyra-
zines, their detection would be rather problematic. 
2 
The lack of evidence for the presence of dihydropyrazines apparent-
ly has resulted in a relative absence of investigation into the chemical 
and biological characteristics of the compounds. Bondarovich ~ al. (7) 
and others have reported that dihydropyrazines have a roasted or nut-
like aroma" Flament and Stoll (9) have reported some physical studies 
on certain alkylated dihydropyrazines. Juneja and Odell (8) have 
investigated the reactivity of alkylated dihydropyrazines toward certain 
dienophiles in an attempt to develop selective trapping agents for their 
detection. There have been no reports on the biological activity of the 
dihydropyrazines. 
This paper reports the synthesis and chemical characterization of 
2,3-dimethyl-5,6-dihydropyrazine. Similar studies have been reported 
earlier by Flament and Stoll (9). The isolation of urinary metabolites 
of 2,3-dimethyl-5,6-dihydropyrazine will also be discussedo 
CHAPTER II 
MATERIALS AND METHODS 
Materials 
Ammonium formate and anhydrous diethyl ether were purchased from 
Fisher Scientific Co., Fair Lawn, New Jersey. Ethylenediamine was 
obtained from Matheson, Coleman and Bell, Norwood, Ohio. 2,3-butane-
dione was purchased from Eastman Organic Chemicals, Rochester, New York. 
Carbowax and Gas Chrome Q were obtained from Applied Science Labora-
tories, Inc., State College, Pe.nnsylvania. Sephadex G-10, Sephadex 
G-15, DEAE-Sephadex A-25, and CM-Sephadex C-25 were purchased from 
Pharmacia Fine Chemicals, Inc., Piscataway, New Jersey. CD-1 Strain, 
white, male mice were obtained from Charles River. 2,3- 14C-2,3-di-
methyl-5,6-dihydropyrazine was a gift from Mr. Ralph Reed, Department 
of Biochemistry, Oklahoma State University. 
Synthesis of 2,3-Dimethyl-5,6-Dihydropyrazine 
The synthesis of 2,3-dimethyl-5,6-dihydropyrazine was based on the 
procedure described by Flament and Stoll (9) involving the condensation 
of ethylenediamine with 2,3-butanedione. The reaction was conducted in 
a one liter round bottom flask with three ground glass necks. In one 
neck was placed a 250 ml dropping funnel. The middle neck was fitted 
with a ground glass stirring rod and sleeve assembly which was connected 
3 
4 
to a stirring motor, The third neck was connected to a 12 inch reflux 
condenser fitted with a tap water cooling jacket. The reaction vessel 
was mounted in an ice-water bath. 
In the synthesis, 0.25 mole of ethylenediamine in 150 ml of ether 
was transferred to the cooled (0°) reaction flask. A solution of Oo25 
mole of 2, 3-butanedione in 215 ml of ether was then added dropwise 
through the dropping funnel while stir.ring the reaction mixture. A 
light tan precipitate formed as the 2,3-butanedione was added. The 
2,3-butanedione was added dropwise over a period of one hour and the 
reaction was allowed to continue for 30 minutes after the last addition, 
The ice-water bath was then removed and the reaction flask warmed to 
25°. 9 The solution was then allowed to stand at 25 until the light tan 
precipitate had dissolved, forming a dark yellow solution. 
The aqueous and ether layers were separated and the aqueous layer 
was extracted four times with 20 ml of diethyl ether. The ether 
extracts were combined with the original ether layer. The volume of the 
ether solution was reduced by removing most of the ether on a rotary 
evaporator at 25°. 
Purification of 2,3-Dimethyl-5,6-Dihydropyrazine 
The purification of 2,3-diitlethyl-5,6-dihydropyrazine was effected 
using fractional distillation under reduced pressure. The reaction 
mixture was transferred to a 250 ml round bottom distillation flask 
with a ground glass neck. The neck was fitted with a silver-mirrored, 
tap water jacketted, three inch reflux condenser with a side arm and 
a ground glass joint fitted with a thermometer. The side arm was 
connected to a water cooled four inch condenser with a vacuum nipple 
connected to a water aspirator. The condenser was connected to a 
collection apparatus fitted with three ground glass male connections to 
which 50 ml round bottom flasks with ~round glass necks were fitted. 
The distillation flask was mounted in a heating mantel controlled by a 
voltage regulator. 
The reaction mixture was then fractionally distilled under vacuum, 
12 mm Hg. The second fraction, which distilled at 60°, was collected 
and saved. Other fractions were discarded and adarkbrown gummy resi-
due was noted in the distillation flask. The purified compound was 
stored under nitrogen. 
Physical Characterization of 2,3-Dimethyl-
5,6-Dihydropyrazine 
Gas-Liquid Chrrunatog.raphy 
5 
A Perkin-Elmer Model 990 gas chromatograph fitted with a flame-
ionization detector was used to determine the purity of the synthesized 
2,3-dimethyl-5,6-dihydropyrazine. The column was a 1/4 inch x 6 foot 
glass column packed with five percent (w/w) Carbowax 20M on Gas Chrome Q 
(100/120 mesh). The column was operated isothermally at 135° using 
nitrogen as the carrier gas. The injector temperature was 175° and the 
detector temperature was 200°. One ul samples were injected neat into 
the gas chromatograph. 
Infrared Spectroscopy 
The infrared spectrum of the synthesized 2,3-dimethyl-5,6-dihydro-
pyrazine was obtained on a Perkin Elmer· Model 457 grating infrared 
6 
spectrophotometer. The compound was scanned neat as a 0.028 nun thick 
film between two sodium chloride plates. 
Magnetic Resonance Spectroscopy 
,j 
The nuclear magnetic resonance spectrum of 2,3-dimethyl-5,6-di-
hydropyrazine was obtained on a Varian 60 megacycle instrument. The 
sample was scanned neat at 25°. 
Mass Spectrometry 
The mass spectrum of synthesized 2,3-dimethyl-5,6-dihydropyrazine 
was determined using a combination gas chromatograph-mass spectrometer. 
The instrument used was a LKB 9000 mass spectrometer, 
Ultraviolet Spectroscopy 
The ultraviolet spectrum of 2,3-dimethyl-5,6-dihydropyrazine was 
obtained on a Hitachi Perkin-Elmer Model 124 double-beam spectrophoto-
meter. A 0,42 M solution of the sample in water was scanned from 360 
nm to 190 nm using de-ionized water in the reference beam. 
Ionization Constants 
The ionization constants of 2,3-dimethyl-5,6-dihydropyrazine were 
determined using a titrimetrictechnique. A Radiometer Model PHM25 
pH meter was used to follow the titration. Fifty ml of a 0,05 M 
solution of the compound in water was titrated with 0.18 M hydrochloric 
acid. Corrections were made for the titration of 50 ml of de-ionized 
water with 0.18 M hydrochloric acid and the volume of titrant used was 
converted to milliequivalents. The first derivative of the titration 
curve was computed to determine the change in buff er capacity as a 
function of a change in pH (~B/~pH). The peaks of the 6B/~pH curve 
were defined as the ionization constants. 
Biological Activity 
Toxicity 
7 
The toxicity of 2,3-dimethyl-5,6-dihydropyrazine was determined by 
the method of Reed and Muench (10), Different dilutions of the compound 
in 0.9 percent saline solution were made and 0.25 ml was injected into 
the test animals. Four white male mice of approximately 25 g were 
injected intraperitoneally with 0.25 ml of the test sample at each 
dilution. All deaths occured within three hours4 · No postmortem 
examinations were performed due to time limitations. 
Daily Urinary Excretion of 14C Labeled Metabolites 
Four white male mice were each injected intraperitoneally with five 
mg of 2,3- 14C-2,3-dimethyl-5,6-dihydropyrazine, 53,400 dpm/mg, in Oo25 
ml of 0.9 percent saline solution. The mice were then placed in a 
metabolic cage mounted above a large funnel fitted with a collection 
flask. The collection flask was suspended in an ice-water bath. During 
the five day test period, the mice were allowed free access to both food 
and water. 
The urine was collected at 24 hour intervals and centrifuged at 
10,000 x g for 15 minutes. The pellet and supernatant were separated 
and the pellet resuspended in water and centrifuged at 10,000 x g for 
15 minutes. The two supernatants were combined and diluted to 250 ml. 
8 
One ml aliquots of the dilution were transferred to a scintillation 
vial and diluted with 10 ml of liquid scintillation solution prepared 
according to the method of Bray (11). The samples were then assayed for 
radiation on a Packard Liquid Scintillation Spectrophotometer Model 
3320. Corrections were made for background, dilutions, and instrument 
efficiency. 
Isolation of Urinary Metabolites 
Ten white male mice were each injectedintrape:ritoneally with five 
mg of 2,3-14C-2,3-dimethyl-5,6-dihydropyrazine in 0.25 ml of 0.9 percent 
saline solution, The mice were then placed in a metabolic cage as above~ 
Since it was determined that most of the 14C label was excreted in the 
first 24 hours, sampling was not continued beyond this time. The 24 
hour urine sample was then centrifuged and the pellet washed as above. 
The sample was then dried by lyophilization. 
The urinary metabolites of 2,3-dimethyl-5,6-dihydropyrazine were 
then isolated using chromatographic techniques, The sampleSi were 
monitored for radiation by assaying 0.1 ml in a liquid scintillation 
system as above, The samples were also followed spectrophotometrically 
by measuring the absorption at 260 nm, 
Anion .Exchange Chroma.tography 
The dried urine sample was diluted to five ml with 0.04 M ammonium 
formate. The sample was then placed on top of an anion exchange column 
and eluted with buffer. Five ml fractions were collected and monitored 
as above. 
The column was a 1.0 cm x 100 cm column packed with DEAE-Sephadex 
A-25 formate form. The eluting buffer was 0.04 M ammonium formate 
solution, pH 6.47. 
Cation Exehange Gh.roma,tagraphy 
9 
The 14C labeled fraction from the anion exchange chromatography was 
dried by lyophilization. The sample was then diluted-to five ml in 0.04 
M ammonium formate solution. The sample was· then placed on top of a 
cation exchange column and eluted by increasing the ammonium formate 
concentration. Four ml fractions were collected and monitored as above. 
The column was a 1.5 cm x 60 cm column packed with CM-Sephadex C-25 
ammonium form. The column was washed with 50 ml of 0.04 M ammonium 
formate, pH 6.47. A linear elution gradient was then initiated. A 
volume of 250 ml of 0.04 M ammonium formate, pH 6.47, was placed in a 
mixing chamber which was attached to a reservoir containing 250 ml of 
1.5 M ammonium formate, pH 6.47. 
Molecular Seive Chromatography 
Sephadex G-15. 14C labeled fractions, designated 2 and 3 from the 
cation exchange chromatography were dried by lyophilization. They were 
diluted to five ml with water and placed on 1.5 cm x 100 cm Sephadex 
G-15 columns, The samples were eluted with water and two ml fractions 
were collected. The samples were monitored as above, 
Sephadex G-10. 14C labeled fractions, designated 2a and 2b from 
the Sephadex G-15 column and 1 from the cation exchange column, were 
dried by lyophilization. They were diluted to five ml with water and 
placed on 1. 5 cm x 100 cm Sephadex G-10 columns, The samples were. 
eluted with water and two ml fractions collected. The samples were 
monitored as above. 
10 
CHAPTER III 
RESULTS AND DISCUSSION 
Synthesis and Purification of 2,3-Dimethyl-
5,6-Dihydropyrazine 
The synthesis of 2,3-dimethyl-5,6-dihydropyrazine (III) was accom-
plished by condensing ethylenediamine (I) with 2,3-butanedione (II) at 
oo, equation 2. The concentrated reaction mixture was dark yellow. 
H2"'-.. .,,,. NH2 o~c_.....cH3 
.,. HXXCH3 y 
+ I 
c ol//l'c, CH (2) H_..... 'NH 2 2 3 H2 CH3 
(I) (IJ) ( 111) 
Fractional distillation under reduced pressure was found to be a very 
satisfactory method for purification. This procedure resulted in 2,3-
dimethyl-5,6-dihydropyrazine that was greater than 99 percent pure, as 
estimated by the gas-liquid chromatographic pattern of Figure 1. The 
purified compound was a light yellow. The synthetic yield, through 
purification, was 13.5 ml which represents a 47 percent yield. This is 
in good agreement with Flament and Stoll (9), who reported a yield of 
50 percent. 
Physical Characterization of 2,3-Dimethyl-
5,6-Dihydropyrazine 
The physical characterization of 2,3-dimethyl-5,6..;.dihydropyrazine 
11 
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was considered necessary for two main reasons. The first reason was to 
verify the structure of the synthesized 2,3-dimethyl-5,6-dihydropyrazine. 
The second reason was to provide a basis for comparison for future 
studies concerned with characterizing . .the metabolites of 2,3-dimethyl-
5,6-dihydropyrazine. Although Flament and Stoll (9) provide a short 
discussion of some of these physical properties, the actual data is not 
provided in the form of usable figures. 
The infrared spectrum of 2,3-dimethyl-5,6-dihydropyrazine is shown 
in Figure 2. The bands at 1652-1647, 1597-1590, 951-925, 896-883, and 
662-645 cm- 1 were reported by Flament and Stoll (9). 
The nuclear magnetic resonance spectrum of 2,3-dimethyl-5,6-dihy-
dropyrazine (Figure 3) indicates the presence of only two types of 
hydrogen atoms. The large peak at 2.05 ppm is consistent with methyl 
hydrogens. The second peak at 3.19 ppm represents the ring hydrogens. 
The measured ratio of these two peaks is 6.0 to 4.0 which is the pre-
dicted ratio for the compound. 
The mass spe·ctral pattern of 2,3-dimethyl-5,6-dihydropyrazine is 
shown in Figure 4. The peak at m/e 110 represents the molecular ion of 
the compound. The identification of the other m/e peaks would require 
high resolution mass spectrometry techniques. 
The ultraviolet spectrum of 2,3-dimethyl-5,6-dihydropyrazine from 
190 nm to 360 nm is shown in Figure 5. The two largest peaks occur at 
200 nm and 225 nm. A smaller peak is observed at 320 nm. _10.g e: for the 
peak at 200 nm is 3.45 and that for the 225 nm peak is 3.29. 
The ionization constants of 2,3-dimethyl-5,6-dihydropyrazine were 
determined (Figure 6). The first ionization constant is 5.9 and the 
second occurs at 1.3. These are considerably higher than those found 
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for pyrazines which are approximately 0.65 and -5.8 respectively. This 
large difference is expected since the lack of aromatization in the 
2,3-dimethyl-5,6-dihydropyrazine generates a less stable ring system 
than is present in the pyrazines. 
Biological Activity of 2,3-Dimethyl-
5;6-Dihydropyrazine 
During early studies with 2,3-dimethyl-5,6-dihydropyrazine, it was 
noted that contact of the compound with the skin resulted in a rapid 
browning of the epidermal tissue., This dark brown stain was extremely 
difficult to remove. It was decided that a compound which binds this 
tightly should be investigated with respect to both toxicity and elim-
ination from the body. 
The toxicity, in terms of LDso, was determined to be 0.36 mg/g 
body weight .. whe.n. i.njected intraperitoneally into white male mice (Figure 
7). The LDso of 2,3-dimethylpyrazine has been reported to be 1.39 mg/g 
body weight in mice. Extreme muscular contractions began iunnediately 
upon injection at the higher concentrations. A hypnotic effect was 
observed at lower concentrations which lasted up to three hours. Doses 
in the range of the LDso resulted in muscular spasms in the animals 
which sometimes lasted up to 1.5 hours but did not always result in 
death. Deaths occurred within three hours. 
Daily urinary excretion of metabolites was monitored· by using 14C 
labeled 2,3-dimethyl-5,6-dihydropyrazine. The percent dose recovered 
was computed as the percentage of the total label injected into four 
white male mice (Figure 8). The largest recovery of label in the urine 
was 43 percent and occurred during the first 24 hours. This compares 
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with 84 percent of the label being excreted in the urine of rats in 24 
hours when 2,3- 14C-2,3-dimethylpyrazine is administered as reported by 
Elgin (12). The total recovery of label during the five day period was 
55 percent. Whether the remainder of the radioactivity was eliminated 
via the respir-e-0 gases or in the feces is unknown. It can be postulated 
that some of the injected compound may have beeome· associated with some 
of the various tissues with which it came into contact. 
Isolation of Urinary Metabolites 
The initial separation of the urinary metabolites of 2,3-dimethyl-
pyrazine, as performed by Reed (13), involves their elution from a 
Dowex 1 x 8 formate form column using low pH and high salt concentra-
tions. It was thought that the metabolites of 2,3-dimethyl-5,6-dihydro-
pyrazine might be similar enough to also utilize anion exchange 
chromatography for their initial separation. Since 2,3-dimethyl-5,6-
dihydropyrazine is chemically less stable than the 2, 3-dimethylpyrazine, 
it was decided that a milder procedure was needed. A DEAE-Sephadex A-25 
formate form column was selected and the elution buffer was 0.04 M 
ammonium formate, pH 6.47. 
The DEAE-Sephadex A-25 column did not separate the urinary metabo-
lites of 2,3-dimethyl-5,6-dihydropyrazine, since all of the 14C label 
eluted in the void volume, designated fraction A (Figure 9). It was 
effective, however, in removing a large amount of the compounds present 
in the urine of the mice. This procedurewastherefore utilized as the 
initial step. 
Three controls were run using identical conditions to the DEAE-
Sephadex system. The first control was half of a 24 hour urine sample 
23 
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from one mouse (Figure 10). The second was five mg of 2,3-dimethyl-
5,6-dihydropyrazine (Figure 11). The third control was five mg of 2,3-
14C-2,3-dimethyl-5,6-dihydropyrazine incubated two hours at 25° with a 
24 hour urine sample from one mouse (Figure 12). 
Since the urinary metabolites did not separate on the anion 
exchange column, the decision was made to attempt the separation of 
fraction A, from the DEAE-Sephadex column, using a cation exchange 
column. The conditions of the separation were again kept mild. A weak 
cation exchange resin, CM-Sephadex C-25, was chosen and the separation 
achieved using an increasing ammonium formate gradient, maintaining the 
pH at 6. 47. 
The CM-Sephadex C-25 column resolved the urinary metabolites into 
three major 14C labeled fractions (Figure 13). These three fractions 
were designated 1, 2, and 3 in order of their elution. 
The two radioactive peaks obtained in the third control for the 
DEAE-Sephadex system (Figure 12) were combined and rechromatographed 
using the CM-Sephadex system. Three 14C labeled fractions were obtained 
(Figure 14) but only one of these could be correlated with the pattern 
for the urinary metabolites of Figure 13. 
The spectrophotometric and 14C labeling pattern (Figure 13) 
indicated that thepurification of the urinary metabolites was not 
complete and molecular seive chromatography was then attempted. 
The· 14C labeled fraction 1 (Figure 13) was rechromatogra:phed using 
a Sephadex G-10 column. Five 14C labeled metabolites were now detected 
and designated la, lb, le, ld, and le (Figure 15). Purification was 
still not compl.ete but time did not allow further efforts. 
The 14C labeled fraction 2 (Figure 13) was rechromatogra:phed using 
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a Sephadex G-15 column. Two 14C labeled fractions were found and were 
designated 2a and 2b (Figure 16). Purification was still not satis-
factory. Fractions 2a and 2b were rechromatographed on Sephadex G-10 
columns (Figures 17 and 18). 
The 14C labeled frqction 3 (Figure 13) was found not to absorb 
light at either 260nm or 280 nm. Fraction 3 wasreehromatographed 
using aSephadex G-15 column (Figure 19). 
The isolation scheme for the urinary metabolites of 2,3-dimethyl-
5,6-dihydropyrazine is shown in Figure 20. It is noted above that the 
purification of the metabolites is not yet complete. Reed (13) has had 
success with various thin-layer and paper chromatographic techniques in 
the isolation of the urinary metabolites of 2,3-dimethylpyrazine. It 
may be possible to use these techniques to further purify the metabo-
lites of 2,3-dimethyl-5,6-dihydropyrazine. 
Reed (13) has established that there are at least four urinary 
metabolites of 2,3-dimethylpyrazine in rats. This study indicates at 
least five minor and three major urinary metabolites of 2,3-dimethyl-
5,6-dihydropyrazine in mice. Future studies might be concerned with 
the comparison of the metabolites of 2,3-dimethylpyrazine and 2,3-
dimethyl-5,6-dihydropyrazine. The percentage of the injected 14C label 
of each of the eight metabolites are shown in Table I. 
Due to time limitations, no attempt has been made to characterize 
the metabolites. Further, the results that could be obtained at this 
stage of purity would be-of little value. Future studies should 
complete the purification and the characterization of the metabolites. 
The localization of the metabolic pirocesses would also be a useful 
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TABLE I 
URINARY METABOLITES OF MICE INJECTED WITH 2,3- 1 ~C-
2,3-DIMETHYL-5,6-DIHYDROPYRAZINE* 
Metabolite Percent Dose 
la 2.7 
lb 1. 7 
le 0.6 
ld 3.8 
le 0.3 
2a 8.2 
2b 17.5 
3 8.1 
24 Hour Total 42.9 
*Ten mice were administered doses of 267,000 dpm each 
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study and could be accomplished by incubation of the 2,3-dimethyl-5,6-
dihydropyrazine with tissue and organ homogenates. 
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CHAPTER IV 
SUMMARY 
The synthesis and purification of 2,3-dimethyl-5,6-dihydropyrazine 
has been performed. The physical characteristics of the compound have 
also been established providing a basis for comparison for future 
studies concerned with the characterization of the metabolites of 2,3-
dimethyl-5,6-dihydropyrazine. 
Studies concerned with the biological activity of 2,3-dimethyl-
5,6-dihydropyrazine in mice indicate a LDso of 0.36 mg/g body weight. 
It was also shown that 43 percent of the administered dose is excreted 
in the urine in 24 hours. 
Biochemical changes in the 2,3-dimethyl-5,6-dihydropyrazine do 
occur and at least five minor and three major metabolites have been 
indicated. Anion exchange, cation exchange, and molecular seive 
chromatographic techniques have been utilized in the purification of 
the urinary metabolites. No studies were conducted to define the 
nature of the major urinary metabolites dae to time limitations. 
Use of the techniques developed in this study mi-ght be helpful in 
future studies on tissue and organ homogenates as well as future studies 
on the urinary metabolites. Future studies should also be concerned 
with the comparison of the metabolites of 2,3-dimethylpyrazine with 
those of 2,3-dimethyl-5,6-dihydropyrazine. 
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